x NoneEntity Type
0001526119
 
x Corporation
o Limited Partnership
o Limited Liability Company
o General Partnership
o Business Trust
o Other
Name of Issuer
 Verastem, Inc.
Jurisdiction of Incorporation/OrganizationDELAWARE 
Year of Incorporation/Organization
  x Over Five Years Ago
  o Within Last Five Years (Specify Year)  
  o Yet to Be Formed 



2. Principal Place of Business and Contact Information
Name of Issuer 
 Verastem, Inc. 
Street Address 1Street Address 2
 117 KENDRICK STREET SUITE 500
CityState/Province/CountryZIP/Postal CodePhone No. of Issuer
 NEEDHAM MASSACHUSETTS 02494 (781) 292-4200 



3. Related Persons
Last NameFirst NameMiddle Name
STUGLIKBRIAN
Street Address 1Street Address 2
C/O VERASTEM, INC.117 KENDRICK STREET, SUITE 500
CityState/Province/CountryZIP/Postal Code
NEEDHAMMASSACHUSETTS02494
Relationship: x Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
GAGNONROB
Street Address 1Street Address 2
C/O VERASTEM, INC.117 KENDRICK STREET, SUITE 500
CityState/Province/CountryZIP/Postal Code
NEEDHAMMASSACHUSETTS02494
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
PATERSONDAN
Street Address 1Street Address 2
C/O VERASTEM, INC.117 KENDRICK STREET, SUITE 500
CityState/Province/CountryZIP/Postal Code
NEEDHAMMASSACHUSETTS02494
Relationship: x Executive Officer o Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
KAUFFMANMICHAEL
Street Address 1Street Address 2
C/O VERASTEM, INC.117 KENDRICK STREET, SUITE 500
CityState/Province/CountryZIP/Postal Code
NEEDHAMMASSACHUSETTS02494
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

 
Last NameFirst NameMiddle Name
BARBERICHTIMOTHY
Street Address 1Street Address 2
C/O VERASTEM, INC.117 KENDRICK STREET, SUITE 500
CityState/Province/CountryZIP/Postal Code
NEEDHAMMASSACHUSETTS02494
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
LAWTONALISON
Street Address 1Street Address 2
C/O VERASTEM, INC.117 KENDRICK STREET, SUITE 500
CityState/Province/CountryZIP/Postal Code
NEEDHAMMASSACHUSETTS02494
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
ROWINSKYERIC
Street Address 1Street Address 2
C/O VERASTEM, INC.117 KENDRICK STREET, SUITE 500
CityState/Province/CountryZIP/Postal Code
NEEDHAMMASSACHUSETTS02494
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

Last NameFirst NameMiddle Name
WENDELBRUCE
Street Address 1Street Address 2
C/O VERASTEM, INC.117 KENDRICK STREET, SUITE 500
CityState/Province/CountryZIP/Postal Code
NEEDHAMMASSACHUSETTS02494
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

 
Last NameFirst NameMiddle Name
CONSYLMANGINA
Street Address 1Street Address 2
C/O VERASTEM, INC.117 KENDRICK STREET, SUITE 500
CityState/Province/CountryZIP/Postal Code
NEEDHAMMASSACHUSETTS02494
Relationship: o Executive Officer x Director o Promoter
Clarification of Response (if Necessary)
  

 


4. Industry Group
o Agriculture Health Care o Retailing
 Banking & Financial Services   o Biotechnology o Restaurants
  o Commercial Banking   o Health Insurance Technology
  o Insurance  o Hospitals & Physicians  o Computers
  o Investing  x Pharmaceuticals  o Telecommunications
  o Investment Banking  o Other Health Care  o Other Technology
  o Pooled Investment Fund

    Travel
  o Other Banking & Financial Services o Manufacturing  o Airlines & Airports
 Real Estate  o Lodging & Conventions
  o Commercial  o Tourism & Travel Services
  o Construction  o Other Travel
  o REITS & Finance o Other
  o Residential 
  o Other Real Estate 
o Business Services 
 Energy 
  o Coal Mining 
  o Electric Utilities 
  o Energy Conservation 
  o Environmental Services 
  o Oil & Gas 
  o Other Energy 


5. Issuer Size
Revenue RangeAggregate Net Asset Value Range
o No Revenues o No Aggregate Net Asset Value
o $1 - $1,000,000 o $1 - $5,000,000
o $1,000,001 - $5,000,000 o $5,000,001 - $25,000,000
o $5,000,001 - $25,000,000 o $25,000,001 - $50,000,000
o $25,000,001 - $100,000,000 o $50,000,001 - $100,000,000
o Over $100,000,000 o Over $100,000,000
x Decline to Disclose o Decline to Disclose
o Not Applicable o Not Applicable


6. Federal Exemption(s) and Exclusion(s) Claimed (select all that apply)
o Rule 504(b)(1) (not (i), (ii) or (iii)) o Rule 505
o Rule 504 (b)(1)(i) o Rule 506(b)
o Rule 504 (b)(1)(ii) x Rule 506(c)
o Rule 504 (b)(1)(iii) o Securities Act Section 4(a)(5)
  o Investment Company Act Section 3(c)

7. Type of Filing
x New Notice Date of First Sale 2020-02-27 o First Sale Yet to Occur
o Amendment

8. Duration of Offering
Does the Issuer intend this offering to last more than one year? o Yes x No

9. Type(s) of Securities Offered (select all that apply)
o Pooled Investment Fund Interests x Equity
o Tenant-in-Common Securities o Debt
o Mineral Property Securities o Option, Warrant or Other Right to Acquire Another Security
o Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security o Other (describe)
  


10. Business Combination Transaction
Is this offering being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer? o Yes x No
 
Clarification of Response (if Necessary) 
  

11. Minimum Investment
Minimum investment accepted from any outside investor$ 0 USD

12. Sales Compensation
RecipientRecipient CRD Number o None
 JEFFERIES LLC 2347
(Associated) Broker or Dealer x None(Associated) Broker or Dealer CRD Number x None
    
Street Address 1Street Address 2
 520 MADISON AVENUE  
City State/Province/CountryZIP/Postal Code
 NEW YORK NEW YORK 10022
State(s) of Solicitation x All States o Foreign/Non-US
 

RecipientRecipient CRD Number o None
 H.C.WAINWRIGHT & CO., LLC 375
(Associated) Broker or Dealer x None(Associated) Broker or Dealer CRD Number x None
    
Street Address 1Street Address 2
 430 PARK AVENUE 4TH FLOOR
City State/Province/CountryZIP/Postal Code
 NEW YORK NEW YORK 10022
State(s) of Solicitation x All States o Foreign/Non-US
 

RecipientRecipient CRD Number o None
 CANTOR FITZGERALD & CO. 134
(Associated) Broker or Dealer x None(Associated) Broker or Dealer CRD Number x None
    
Street Address 1Street Address 2
 110 EAST 59TH STREET 4TH FLOOR
City State/Province/CountryZIP/Postal Code
 NEW YORK NEW YORK 10022
State(s) of Solicitation x All States o Foreign/Non-US
 

 



13. Offering and Sales Amounts
Total Offering Amount $ 100000000 USD o Indefinite
Total Amount Sold $ 100000000 USD 
Total Remaining to be Sold $ 0 USD o Indefinite
 
Clarification of Response (if Necessary)
  


14. Investors
o Select if securities in the offering have been or may be sold to persons who do not qualify as accredited investors,
Number of such non-accredited investors who already have invested in the offering
 
  Regardless of whether securities in the offering have been or may be sold to persons who do not qualify as accredited investors, enter the total number of investors who already have invested in the offering: 21


15. Sales Commissions & Finders’ Fees Expenses
Provide separately the amounts of sales commissions and finders' fees expenses, if any. If the amount of an expenditure is not known, provide an estimate and check the box next to the amount.
Sales Commissions$ 6000000 USD o Estimate
Finders' Fees$ 0 USD o Estimate
 
Clarification of Response (if Necessary)
  


16. Use of Proceeds
Provide the amount of the gross proceeds of the offering that has been or is proposed to be used for payments to any of the persons required to be named as executive officers, directors or promoters in response to Item 3 above. If the amount is unknown, provide an estimate and check the box next to the amount.
 $ 0 USD o
Verastem (NASDAQ:VSTM)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Verastem Charts.
Verastem (NASDAQ:VSTM)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Verastem Charts.

Verastem, Inc. News

Verastem Oncology Announces Appointment of John Hayslip, M.D., to Chief Medical Officer
Thursday 18 April 2024 (1 week ago) • Business Wire
Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Thursday 4 April 2024 (3 weeks ago) • Business Wire
Global Patient Survey Results Reveal Significant Negative Impact on Social, Emotional and Mental Well-Being for People Living with Low-Grade Serous Ovarian Cancer
Monday 18 March 2024 (1 month ago) • Business Wire
Verastem Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Updates
Thursday 14 March 2024 (1 month ago) • Business Wire
Form SC TO-I/A - Tender offer statement by Issuer: [Amend]
Monday 11 March 2024 (2 months ago) • Edgar (US Regulatory)
Verastem Oncology Announces Multiple Oral Presentations at SGO 2024 Annual Meeting on Women’s Cancer that Highlight Advances in Low-Grade Serous Ovarian Cancer Research and Reinforce Commitment to Addressing Urgent Unmet Needs
Monday 11 March 2024 (2 months ago) • Business Wire
Verastem Oncology Receives Orphan Drug Designation from FDA for Avutometinib Alone or in Combination With Defactinib in Recurrent Low-Grade Serous Ovarian Cancer
Tuesday 5 March 2024 (2 months ago) • Business Wire
Verastem Oncology Announces Preclinical Presentations for New Oral G12D Inhibitor and for Avutometinib and Defactinib Combination as a Backbone of Therapy for RAS/MAPK Driven Cancers at AACR Annual Meeting 2024
Tuesday 5 March 2024 (2 months ago) • Business Wire
Form SC TO-I - Tender offer statement by Issuer
Thursday 8 February 2024 (3 months ago) • Edgar (US Regulatory)
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Friday 2 February 2024 (3 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Monday 29 January 2024 (3 months ago) • Edgar (US Regulatory)
Verastem Oncology Outlines Key 2024 Strategic Priorities and Upcoming Catalysts for Advancing Avutometinib and Defactinib and Broader Pipeline in RAS Pathway-Driven Cancers
Monday 29 January 2024 (3 months ago) • Business Wire

More Verastem, Inc. News Articles